MX379052B - Suspensiones farmaceuticas liquidas que contienen bismuto. - Google Patents

Suspensiones farmaceuticas liquidas que contienen bismuto.

Info

Publication number
MX379052B
MX379052B MX2016013886A MX2016013886A MX379052B MX 379052 B MX379052 B MX 379052B MX 2016013886 A MX2016013886 A MX 2016013886A MX 2016013886 A MX2016013886 A MX 2016013886A MX 379052 B MX379052 B MX 379052B
Authority
MX
Mexico
Prior art keywords
liquid pharmaceutical
suspensions containing
containing bismuth
pharmaceutical suspensions
bismuth
Prior art date
Application number
MX2016013886A
Other languages
English (en)
Other versions
MX2016013886A (es
Inventor
Jr Daniel Jerome White
Graham John Myatt
Michael Selden Godlewski
Timothy Charles Gulbin
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2016013886A publication Critical patent/MX2016013886A/es
Publication of MX379052B publication Critical patent/MX379052B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una suspensión farmacéutica líquida para la administración por vía oral que contiene un agente farmacéutico que contiene bismuto, un sistema de suspensión, y agua. El sistema de suspensión puede contener de aproximadamente 0.001 % a aproximadamente 0.2 % de goma gelana y aproximadamente 0.001 % a aproximadamente 0.75 % de silicato de magnesio y aluminio.
MX2016013886A 2014-04-29 2015-04-29 Suspensiones farmaceuticas liquidas que contienen bismuto. MX379052B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461985650P 2014-04-29 2014-04-29
PCT/US2015/028216 WO2015168242A1 (en) 2014-04-29 2015-04-29 Bismuth-containing liquid pharmaceutical suspensions

Publications (2)

Publication Number Publication Date
MX2016013886A MX2016013886A (es) 2017-02-02
MX379052B true MX379052B (es) 2025-03-11

Family

ID=53055136

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013886A MX379052B (es) 2014-04-29 2015-04-29 Suspensiones farmaceuticas liquidas que contienen bismuto.

Country Status (9)

Country Link
US (3) US9486460B2 (es)
EP (1) EP3137056B1 (es)
CN (1) CN106456540B (es)
AU (1) AU2015253188B2 (es)
CA (1) CA2943422C (es)
MX (1) MX379052B (es)
PL (1) PL3137056T3 (es)
RU (1) RU2676261C2 (es)
WO (1) WO2015168242A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2943422C (en) * 2014-04-29 2020-03-10 The Procter & Gamble Company Bismuth-containing liquid pharmaceutical suspensions
CA2943420C (en) * 2014-04-29 2019-06-25 The Procter & Gamble Company Method for making bismuth-containing liquid pharmaceutical suspensions
CN108721325B (zh) * 2017-04-13 2020-03-06 辽宁大熊制药有限公司 蒙脱石混悬液及其制备方法
US20200179411A1 (en) 2017-08-25 2020-06-11 L. Perrigo Company Pharmaceutical suspensions for bismuth subsalicylates
CN109718201B (zh) * 2019-03-18 2021-05-25 烟台市东盛生物科技有限公司 一种治疗急性腹泻的蒙脱石混悬液及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1269987A (en) 1968-04-18 1972-04-12 Garland Richard Brown Antacid composition
US4801454A (en) * 1986-07-17 1989-01-31 The Proctor & Gamble Company Processes for making colored pharmaceutical compositions
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
FR2703250A1 (fr) 1993-03-30 1994-10-07 Chicouri Marcel Nouvelles compositions pharmaceutiques à base de bismuth et leur procédé de préparation.
US20010016577A1 (en) * 1998-08-24 2001-08-23 Douglas Joseph Dobrozsi Oral mucoadhesive compositions containing gastrointestinal actives
US6712496B2 (en) * 2001-07-26 2004-03-30 The Procter & Gamble Company Auger fed mixer apparatus and method of using
CN100400050C (zh) * 2002-02-04 2008-07-09 麦克尼尔-Ppc股份有限公司 用于治疗胃肠疾病的稳定药物组合物
CN1638804A (zh) 2002-03-04 2005-07-13 美德阿利克斯株式会社 在生物体内相转移的液态基质以及液态口服制剂
ATE516019T1 (de) * 2004-05-11 2011-07-15 Egalet Ltd Quellbare dosierform mit gellan-gummit
EP1996688B1 (en) 2006-03-22 2011-10-26 The Procter & Gamble Company Liquid treatment composition
US20080227892A1 (en) 2007-03-13 2008-09-18 Van Der Wielen Maarten Paint formulations comprising cellulose ether/network building polymer fluid gel thickeners
US8394752B2 (en) 2008-12-18 2013-03-12 The Procter & Gamble Company Pearlescent agent slurry for liquid treatment composition
CN102976406B (zh) * 2012-12-27 2014-07-30 湖南金旺铋业股份有限公司 一种用粗氧化铋生产次硝酸铋的工艺
CA2943420C (en) * 2014-04-29 2019-06-25 The Procter & Gamble Company Method for making bismuth-containing liquid pharmaceutical suspensions
CA2943422C (en) * 2014-04-29 2020-03-10 The Procter & Gamble Company Bismuth-containing liquid pharmaceutical suspensions

Also Published As

Publication number Publication date
RU2016138028A (ru) 2018-05-29
AU2015253188A1 (en) 2016-10-06
EP3137056B1 (en) 2020-12-02
RU2016138028A3 (es) 2018-05-29
EP3137056A1 (en) 2017-03-08
US20180303947A1 (en) 2018-10-25
US10039835B2 (en) 2018-08-07
MX2016013886A (es) 2017-02-02
WO2015168242A1 (en) 2015-11-05
US9486460B2 (en) 2016-11-08
US10632200B2 (en) 2020-04-28
PL3137056T3 (pl) 2021-05-04
AU2015253188B2 (en) 2017-09-28
US20170021027A1 (en) 2017-01-26
CA2943422C (en) 2020-03-10
US20150306113A1 (en) 2015-10-29
CN106456540A (zh) 2017-02-22
CA2943422A1 (en) 2015-11-05
BR112016025036A2 (pt) 2017-08-15
CN106456540B (zh) 2020-02-21
RU2676261C2 (ru) 2018-12-27

Similar Documents

Publication Publication Date Title
MX2020006957A (es) Composicion de liberacion modificada que comprende un cannabinoide.
WO2015069773A8 (en) Devices and methods for continuous drug delivery via the mouth
DOP2017000306A (es) Formulaciones farmacéuticas que contienen tenofovir y emtricitabina
MX379052B (es) Suspensiones farmaceuticas liquidas que contienen bismuto.
EP3498264A4 (en) PHARMACEUTICAL PREPARATION WITH TAMSULOSIN HYDROCHLORIDE-CONTAINING PELLETS WITH DELAYED RELEASE FOR ORAL ADMINISTRATION AT CONTROLLED RESOLUTION SPEED
MX2017003205A (es) Composiciones antimicrobianas y sus metodos de uso.
ECSP16084317A (es) Formulaciones farmacéuticas, procesos para la preparación y métodos de uso
CL2015003468A1 (es) Composicion solida para administracion oral conteniendo acido ibandronico o una sal farmaceuticamente aceptable del mismo y vitamina d.
EP3784214A4 (en) LIQUID ORAL PHARMACEUTICAL DOSAGE FORM
ES3060767T3 (en) Alginate film comprising a triptan
CL2017000230A1 (es) Composición adhesiva
AR090073A1 (es) N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos
CL2012003341A1 (es) Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades.
CL2017003088A1 (es) Dispositivo para el cuidado bucal.
CL2017001039A1 (es) Composiciones anti-transpirantes anhidras
EP3302443A4 (en) MECHANO SENSITIVE MICRO CAPSULES FOR DRUG DELIVERY
CL2017003086A1 (es) Dispositivo para el cuidado bucal.
MX387472B (es) Composiciones para el cuidado bucal y sistema para dispensar las mismas.
FR3024733B1 (fr) Agent epaississant pour systemes aqueux, formulations le contenant et utilisations.
AR103188A1 (es) Formulaciones de paracetamol inyectables
FR3017029B1 (fr) Principe actif nutritionnel obtenu a partir de vaccinium angustifolium, composition le contenant et utilisation
ES2645481T3 (es) Tableta dispersable de misoprostol
MX2018004608A (es) Concentrado de detergente liquido.
ITUA20162893A1 (it) Sistema di erogazione di un liquido e metodo per utilizzare tale sistema di erogazione.
FR3030531B1 (fr) Agent epaississant pour systemes aqueux, formulations le contenant et utilisations